Cite
IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C.
MLA
Chayama, Kazuaki, et al. “IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C.” Journal of Infectious Diseases, vol. 204, no. 1, July 2011, pp. 84–93. EBSCOhost, https://doi.org/10.1093/infdis/jir210.
APA
Chayama, K., Hayes, C. N., Abe, H., Miki, D., Ochi, H., Karino, Y., Toyota, J., Nakamura, Y., Kamatani, N., Sezaki, H., Kobayashi, M., Akuta, N., Suzuki, F., & Kumada, H. (2011). IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C. Journal of Infectious Diseases, 204(1), 84–93. https://doi.org/10.1093/infdis/jir210
Chicago
Chayama, Kazuaki, C. Nelson Hayes, Hiromi Abe, Daiki Miki, Hidenori Ochi, Yoshiyasu Karino, Joji Toyota, et al. 2011. “IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C.” Journal of Infectious Diseases 204 (1): 84–93. doi:10.1093/infdis/jir210.